Menu: Home :: go to Journal :: switch to Russian :: switch to English
You are here: all Journals and Issues→ Journal→ Issue→ Article

Role of nuclear proliferating antigen and p53 in the tumor process in gastric cancer

Annotation

Was made the review of literature about the meaning of nuclear proliferating antigen(PCNA) and protein p53 in tumor progression at gastric cancer. Was showed that PCNA depends on the level of invasion of tumor in the side of stomach, stage of process, the size of tumor and may serve as a marker for evaluating aggression of tumor process. Were given data that the level of expression of protein p53 is connected with the form, degree of invasion, and also the localization of tumor in stomach. The authors showed that mutation of p53 in tumor grows at localization of tumor in cardinal segment. Was also studied the frequency of mutations of p53 in tumor textile at 26 people having gastric cancer. Wherein was revealed tendency to its growing as was growing the level of invasion. Were showed the meanings of PNCA and p53 for the length of life of people having gastric cancer.

Keywords

early gastric cancer; proliferating nuclear antigen; p53; tumor progression; prediction

Full-text in one file

Download

UDC

616-006

Pages

140-142

References

1. McCormick D., Hall P.A. The complexities of proliferating cell nuclear antigen // Histopathology. 1992. V. 21. P. 591-543. 2. Hall P.A., Levison D.A., Woods A.L. et al. Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms // J. Pathol. 1990. V. 162. P. 285-294. 3. Miyachi K., Fritzler M.J., Tan E.M. Autoantibody to a nuclear antigen in proliferating cells // J. Immunol. 1978. V. 121 (6). P. 2228-2234. 4. Maga G., Hubscher U. Proliferating cell nuclear antigen (PCNA): a dancer with many partners // J. Cell Sci. 2006. V. 116. P. 3051-3060. 5. Moldovan G.L., Pfander B., Jentsch S. PCNA, the maestro of the replication fork // Cell. 2007. V. 129 (4). P. 665-679. 6. Paunesku T., Mittal S., Protić M. Proliferating cell nuclear antigen (PCNA): ringmaster of the genome // Int. J. Radiat. Biol. 2001. V. 77. P. 1007-1021. 7. Kelman Z. PCNA: structure, functions and interactions // Oncogene. 1997. V. 14 (6). P. 629-640. 8. Komatsu K., Wharton W., Hang H. et al. PCNA interacts with hHus1/hRad9 in response to DNA damage and replication inhibition // Oncogene. 2000. V. 19 (46). P. 5291-5297. 9. Stoimenov I., Helleday T. PCNA on the crossroad of cancer // Biochem. Soc. Trans. 2009. V. 37 (Pt 3). P. 605-613. 10. Mailand N., Gibbs-Seymour I., Bekker-Jensen S. Regulation of PCNA-protein interactions for genome stability // Nat. Rev. Mol. Cell Biol. 2013. V. 14. P. 269-282. 11. Witko-Sarsat V., Mocek J., Bouayad D. et al. Proliferating cell nuclear antigen acts as a cytoplasmic platform controlling human neutrophil survival // J. Exp. Med. 2010. V. 207 (12). P. 2631-2645. 12. Naryzhny S., Lee H. Proliferating cell nuclear antigen in the cytoplasm interacts with components of glycolysis and cancer // FEBS Lett. 2010. V. 584 (20). P. 4292-4298. 13. Rosental B., Brusilovsky M., Hadad U. et al. Proliferating cell nuclear antigen is a novel inhibitory ligand for the natural cytotoxicity receptor NKp44 // J. Immunol. 2011. V. 187 (11). P. 5693-5702. 14. Ogden G., Chisholm D., Kiddie R., Lane D. P53 protein in odontogenic cysts: increased expression in some odontogenic keratocysts // J Clin. Pathol. 1992. V. 45 (11). P. 1007-1010. 15. Maedera K., Chung Y., Onoda N. et al. Proliferating cell nuclear anti-gen labeling index of preoperative biopsy specimens in gastric carci-noma with special reference to prognosis // Cancer. 1994. V. 73 (1). P. 528-533. 16. Lee K.E., Lee H.J., Kim Y.H. et al. Prognostic significance of p53, nm23, PCNA and c-erbB-2 in gastric cancer // Jpn. J. Clin. Oncol. 2003. V. 33 (4). P. 173-179. 17. Elpek G.O., Gelen T., Aksoy N.H et al. Microvessel count, proliferating cell nuclear antigen and Ki-67 indices in gastric adenocarcinoma // Pa-thol. Oncol. Res. 2000. V. 6 (1). P. 59-64. 18. Czyzewska J., Guziñska-Ustymowicz K., Lebelt A. et al. Evaluation of proliferating markers Ki-67, PCNA in gastric cancers // Roczniki Aka-demii Medycznej w Bialymstoku. 2004. V. 49 (Suppl. 1). P. 64-66. 19. De Sousa F.A., Paradella T.C., Carvalho Y.R., Rosa L.E. Comparative analysis of cell proliferation ratio in oral lichen planus, epithelial dysplasia and oral squamous cell carcinoma // Med. Oral. Patol. Oral. Cir. Bucal. 2009. V. 14 (11). P. 563-567. 20. Takeda Y., Yashima K., Hayashi A. et al. Expression of AID, p53 and Mlh1 proteins in endoscopically resected differentiated-type early gastric cancer // World J. Gastrointest. Oncol. 2012. V. 4 (6). P. 131-137. 21. Elistratova E.P., Laktionov P.P., Shekestuk P.I. et al. Immunochemical and Molecular-Genetic Markers in Diagnostic of Gastic Cancer // Biomed. Khim. 2009. V. 55 (1). P. 15-31. 22. Joo Y.-E., Chung I.-J., Park Y.-K. et al. Expression of Cyclooxygenase-2, p53 and Ki-67 in gastric cancer // J. Korean Med. Sci. 2006. V. 21 (5). P. 871-876. 23. Lee W.-S., Kim H.-S., Choi S.-K., Rew J.-S. Expression of Cyclooxyge-nase-2, p53 and Ki-67 in Gastric Cancer // J. Korean Med. Sci. 2006. V. 21 (5). P. 871-876. 24. Lazarev A., Klimachev V., Zor'kin V. i dr. Osobennosti markerov Ki-67, PCNA, r53 i aktivnosti neoangiogeneza v prognoze raka zheludka // Rossiyskiy bioterapevticheskiy zhurnal. 2010. Vyp. 9 (4). S. 117-122. 25. Chang V., Ivannikov A., Ognerubov N., Bulycheva I., Kushlinskiy N. Ekspressiya belka p53 v opukholyakh bol'nykh rakom zheludka // Per-spektivy razvitiya nauki i obrazovaniya: sbornik materialov Mezhdunar. nauch.-prakt. konf.: v 5 ch. M., 2014. Ch. 1. C. 54-56. 26. Wang S.-C. PCNA: a silent housekeeper or a potential therapeutic target // Trends Pharmacol. Sci. 2014. V. 35 (4). P. 178-186.

Received

2015-01-14

Section of issue

Scientific articles

Для корректной работы сайта используйте один из современных браузеров. Например, Firefox 55, Chrome 60 или более новые.